AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Surgery Partners, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Surgery Partners, Inc. (Nasdaq: SGRY) filed a Form 8-K dated 5 Aug 2025. Under Item 2.02, the Company states it has furnished—not filed—a press release (Exhibit 99.1) that outlines results for the three- and six-month periods ended 30 Jun 2025. No numerical performance data are included in the 8-K itself. The filing notes that any non-GAAP measures discussed in the release are reconciled to the most comparable GAAP figures within that exhibit. Pursuant to General Instruction B.2, the furnished information is not subject to Section 18 liability and is not incorporated by reference into other SEC filings. Exhibit 104 provides the Inline XBRL cover page tag set.

Surgery Partners, Inc. (Nasdaq: SGRY) ha presentato un Modulo 8-K datato 5 agosto 2025. Ai sensi del Punto 2.02, la Società dichiara di aver fornito—e non depositato—un comunicato stampa (Esibizione 99.1) che illustra i risultati relativi ai periodi di tre e sei mesi terminati il 30 giugno 2025. Nel modulo 8-K non sono inclusi dati numerici sulle performance. La documentazione specifica che eventuali misure non GAAP discusse nel comunicato sono riconciliate con le corrispondenti cifre GAAP più comparabili all'interno di tale esibizione. In conformità alle Istruzioni Generali B.2, le informazioni fornite non sono soggette alla responsabilità ai sensi della Sezione 18 e non sono incorporate per riferimento in altri documenti SEC. L'Esibizione 104 contiene il set di tag Inline XBRL per la pagina di copertina.

Surgery Partners, Inc. (Nasdaq: SGRY) presentó un Formulario 8-K con fecha 5 de agosto de 2025. Bajo el Punto 2.02, la Compañía indica que ha proporcionado—no presentado—un comunicado de prensa (Exhibición 99.1) que detalla los resultados de los períodos de tres y seis meses finalizados el 30 de junio de 2025. No se incluyen datos numéricos de desempeño en el propio 8-K. El documento señala que cualquier medida no GAAP mencionada en el comunicado se reconcilia con las cifras GAAP más comparables dentro de esa exhibición. Conforme a la Instrucción General B.2, la información proporcionada no está sujeta a la responsabilidad de la Sección 18 y no se incorpora por referencia en otros archivos ante la SEC. La Exhibición 104 contiene el conjunto de etiquetas Inline XBRL para la portada.

Surgery Partners, Inc. (Nasdaq: SGRY)ëŠ� 2025ë…� 8ì›� 5ì¼ìž Form 8-Kë¥� 제출했습니다. 항목 2.02ì—� ë”°ë¼ íšŒì‚¬ëŠ� 2025ë…� 6ì›� 30ì� 종료ë� 3개월 ë°� 6개월 기간ì� 실ì ì� 요약í•� ë³´ë„ìžë£Œ(전시ë¬� 99.1)ë¥� 제출í•� ê²ƒì´ ì•„ë‹ˆë� 제공했다ê³� 명시했습니다. 8-K ìžì²´ì—는 수치 성과 ë°ì´í„°ê°€ í¬í•¨ë˜ì–´ 있지 않습니다. 제출 문서ì—는 ë³´ë„ìžë£Œì—서 ë…¼ì˜ë� ë¹�-GAAP 지표가 해당 전시ë¬� ë‚´ì—ì„� ê°€ìž� 유사í•� GAAP 수치와 ì¡°ì •ë˜ì–´ 있ìŒì� 명시하고 있습니다. ì¼ë°˜ ì§€ì¹� B.2ì—� ë”°ë¼ ì œê³µë� ì •ë³´ëŠ� 섹션 18 ì±…ìž„ 대ìƒì´ 아니ë©� 다른 SEC 제출 문서ì—� 참조ë¡� í¬í•¨ë˜ì§€ 않습니다. 전시ë¬� 104ëŠ� ì¸ë¼ì� XBRL 표지 태그 세트ë¥� 제공합니ë‹�.

Surgery Partners, Inc. (Nasdaq : SGRY) a déposé un formulaire 8-K daté du 5 août 2025. En vertu du point 2.02, la Société déclare avoir fourni—et non déposé—un communiqué de presse (Exhibit 99.1) qui présente les résultats des périodes de trois et six mois terminées au 30 juin 2025. Aucun chiffre de performance n’est inclus dans le 8-K lui-même. Le dépôt précise que toute mesure non-GAAP mentionnée dans le communiqué est rapprochée des chiffres GAAP les plus comparables au sein de cette annexe. Conformément à l’Instruction Générale B.2, les informations fournies ne sont pas soumises à la responsabilité en vertu de la Section 18 et ne sont pas incorporées par référence dans d’autres dépôts auprès de la SEC. L’Exhibit 104 fournit l’ensemble des balises Inline XBRL pour la page de couverture.

Surgery Partners, Inc. (Nasdaq: SGRY) reichte am 5. August 2025 ein Formular 8-K ein. Unter Punkt 2.02 gibt das Unternehmen an, eine Pressemitteilung (Anlage 99.1), die die Ergebnisse der drei- und sechsmonatigen Perioden zum 30. Juni 2025 darlegt, bereitgestellt—nicht eingereicht—zu haben. Im 8-K selbst sind keine numerischen Leistungsdaten enthalten. Die Einreichung weist darauf hin, dass alle in der Pressemitteilung besprochenen Non-GAAP-Kennzahlen in der Anlage mit den am besten vergleichbaren GAAP-Zahlen abgeglichen werden. Gemäß der Allgemeinen Anweisung B.2 unterliegt die bereitgestellte Information nicht der Haftung gemäß Abschnitt 18 und wird nicht durch Verweis in andere SEC-Einreichungen aufgenommen. Anlage 104 enthält das Inline-XBRL-Titelseiten-Tag-Set.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine 8-K furnishing Q2-25 earnings press release; no figures disclosed; neutral investment impact.

The filing merely alerts investors that the Company has released its second-quarter 2025 results via a separate press release. Because the 8-K carries no financial metrics, it does not, by itself, change the investment thesis. The use of Item 2.02 and the “furnished, not filed� language shields the disclosures from Section 18 liability, following standard practice for earnings releases. Investors must consult Exhibit 99.1 for revenue, EPS, margin trends or guidance data before making any assessment. Overall impact is neutral until those numbers are reviewed.

Surgery Partners, Inc. (Nasdaq: SGRY) ha presentato un Modulo 8-K datato 5 agosto 2025. Ai sensi del Punto 2.02, la Società dichiara di aver fornito—e non depositato—un comunicato stampa (Esibizione 99.1) che illustra i risultati relativi ai periodi di tre e sei mesi terminati il 30 giugno 2025. Nel modulo 8-K non sono inclusi dati numerici sulle performance. La documentazione specifica che eventuali misure non GAAP discusse nel comunicato sono riconciliate con le corrispondenti cifre GAAP più comparabili all'interno di tale esibizione. In conformità alle Istruzioni Generali B.2, le informazioni fornite non sono soggette alla responsabilità ai sensi della Sezione 18 e non sono incorporate per riferimento in altri documenti SEC. L'Esibizione 104 contiene il set di tag Inline XBRL per la pagina di copertina.

Surgery Partners, Inc. (Nasdaq: SGRY) presentó un Formulario 8-K con fecha 5 de agosto de 2025. Bajo el Punto 2.02, la Compañía indica que ha proporcionado—no presentado—un comunicado de prensa (Exhibición 99.1) que detalla los resultados de los períodos de tres y seis meses finalizados el 30 de junio de 2025. No se incluyen datos numéricos de desempeño en el propio 8-K. El documento señala que cualquier medida no GAAP mencionada en el comunicado se reconcilia con las cifras GAAP más comparables dentro de esa exhibición. Conforme a la Instrucción General B.2, la información proporcionada no está sujeta a la responsabilidad de la Sección 18 y no se incorpora por referencia en otros archivos ante la SEC. La Exhibición 104 contiene el conjunto de etiquetas Inline XBRL para la portada.

Surgery Partners, Inc. (Nasdaq: SGRY)ëŠ� 2025ë…� 8ì›� 5ì¼ìž Form 8-Kë¥� 제출했습니다. 항목 2.02ì—� ë”°ë¼ íšŒì‚¬ëŠ� 2025ë…� 6ì›� 30ì� 종료ë� 3개월 ë°� 6개월 기간ì� 실ì ì� 요약í•� ë³´ë„ìžë£Œ(전시ë¬� 99.1)ë¥� 제출í•� ê²ƒì´ ì•„ë‹ˆë� 제공했다ê³� 명시했습니다. 8-K ìžì²´ì—는 수치 성과 ë°ì´í„°ê°€ í¬í•¨ë˜ì–´ 있지 않습니다. 제출 문서ì—는 ë³´ë„ìžë£Œì—서 ë…¼ì˜ë� ë¹�-GAAP 지표가 해당 전시ë¬� ë‚´ì—ì„� ê°€ìž� 유사í•� GAAP 수치와 ì¡°ì •ë˜ì–´ 있ìŒì� 명시하고 있습니다. ì¼ë°˜ ì§€ì¹� B.2ì—� ë”°ë¼ ì œê³µë� ì •ë³´ëŠ� 섹션 18 ì±…ìž„ 대ìƒì´ 아니ë©� 다른 SEC 제출 문서ì—� 참조ë¡� í¬í•¨ë˜ì§€ 않습니다. 전시ë¬� 104ëŠ� ì¸ë¼ì� XBRL 표지 태그 세트ë¥� 제공합니ë‹�.

Surgery Partners, Inc. (Nasdaq : SGRY) a déposé un formulaire 8-K daté du 5 août 2025. En vertu du point 2.02, la Société déclare avoir fourni—et non déposé—un communiqué de presse (Exhibit 99.1) qui présente les résultats des périodes de trois et six mois terminées au 30 juin 2025. Aucun chiffre de performance n’est inclus dans le 8-K lui-même. Le dépôt précise que toute mesure non-GAAP mentionnée dans le communiqué est rapprochée des chiffres GAAP les plus comparables au sein de cette annexe. Conformément à l’Instruction Générale B.2, les informations fournies ne sont pas soumises à la responsabilité en vertu de la Section 18 et ne sont pas incorporées par référence dans d’autres dépôts auprès de la SEC. L’Exhibit 104 fournit l’ensemble des balises Inline XBRL pour la page de couverture.

Surgery Partners, Inc. (Nasdaq: SGRY) reichte am 5. August 2025 ein Formular 8-K ein. Unter Punkt 2.02 gibt das Unternehmen an, eine Pressemitteilung (Anlage 99.1), die die Ergebnisse der drei- und sechsmonatigen Perioden zum 30. Juni 2025 darlegt, bereitgestellt—nicht eingereicht—zu haben. Im 8-K selbst sind keine numerischen Leistungsdaten enthalten. Die Einreichung weist darauf hin, dass alle in der Pressemitteilung besprochenen Non-GAAP-Kennzahlen in der Anlage mit den am besten vergleichbaren GAAP-Zahlen abgeglichen werden. Gemäß der Allgemeinen Anweisung B.2 unterliegt die bereitgestellte Information nicht der Haftung gemäß Abschnitt 18 und wird nicht durch Verweis in andere SEC-Einreichungen aufgenommen. Anlage 104 enthält das Inline-XBRL-Titelseiten-Tag-Set.

0001638833FALSE00016388332025-08-052025-08-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2025
Surgery Partners, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware001-3757647-3620923
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
340 Seven Springs Way, Suite 600
Brentwood, Tennessee 37027
(Address of Principal Executive Offices) (Zip Code)
(615) 234-5900
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareSGRYThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02 Results of Operations and Financial Condition.
On August 5, 2025, Surgery Partners, Inc. issued a press release announcing results for the three and six months ended June 30, 2025. See the press release attached as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
Surgery Partners makes reference to non-GAAP financial measures in the attached press release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP financial measures is provided therein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
99.1
Press release dated August 5, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SURGERY PARTNERS, INC.
Date:
August 5, 2025By:/s/ David T. Doherty
David T. Doherty
Executive Vice President and Chief Financial Officer


FAQ

When did Surgery Partners (SGRY) file this 8-K?

August 5, 2025.

What event is disclosed in the 8-K?

The company furnished a press release announcing results for the quarter and six months ended June 30 2025.

Which exhibit contains the earnings press release?

Exhibit 99.1 holds the full press release dated August 5 2025.

Does the 8-K include GAAP or non-GAAP numbers?

No, the filing itself contains no financial figures; reconciliations are within the press release.

What item of the Exchange Act does this filing address?

It pertains to Item 2.02 � Results of Operations and Financial Condition.
Surgery Partners Inc

NASDAQ:SGRY

SGRY Rankings

SGRY Latest News

SGRY Latest SEC Filings

SGRY Stock Data

2.84B
76.28M
1.51%
111.57%
9.24%
Medical Care Facilities
Services-general Medical & Surgical Hospitals, Nec
United States
BRENTWOOD